<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00555386</url>
  </required_header>
  <id_info>
    <org_study_id>R14697</org_study_id>
    <secondary_id>07/Q0101/10</secondary_id>
    <nct_id>NCT00555386</nct_id>
  </id_info>
  <brief_title>Soy, Selenium and Breast Cancer Risk</brief_title>
  <official_title>A Pilot Study to Determine the Effect of Dietary Intervention on Novel Biomarkers of Breast Cancer Risk.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of East Anglia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Quadram Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Big C Local Cancer Research and Care</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Clinical Research and Trials Unit (Norfolk &amp; Norwich University Hospital, UK)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of East Anglia</source>
  <brief_summary>
    <textblock>
      There is evidence to suggest that some dietary components can reduce the risk of breast
      cancer. In this pilot study two such components, isoflavones (compounds found in soy
      products) and selenium, will be given to women classed as at moderate to high risk of the
      disease. The aim is to determine some novel biomarkers of risk and to see the effect of
      supplementation on them.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The high incidence of breast cancer, its relatively long development phase and the financial
      burden to the NHS in relation to treatment makes it a prime target for dietary preventative
      strategies. Epidemiological and experimental investigations suggest several key dietary
      components that may reduce breast cancer, in particular isoflavones and selenium. Few dietary
      intervention studies have been conducted to investigate putative protective effects, but with
      our growing understanding of cancer biology and the application of new -omics technologies it
      is now possible to use early biomarkers of risk to assess the potential efficacy of
      intervention studies.

      In this pilot project, we will employ a combination of disciplines to examine the effect of
      dietary intervention in a group of women defined by NICE guidelines as being at increased
      risk (moderate-high) of developing breast cancer, using metabolomics to assess the
      tractability of biomarkers in response to the dietary intervention. Such trials are urgently
      needed to examine the protective effects of diet in women classified at increased risk and
      who are still in the 'zone of reversibility'. The results of this study will be used to
      justify and optimise larger scale intervention trials and ultimately to develop appropriate
      dietary recommendations for the prevention of breast cancer.

      A dietary intervention study based on a randomised double-blind parallel design will be
      conducted in 30 pre-menopausal women (age 35-50) at moderate to high risk of developing
      breast cancer. The metabolomic profiles of urine and serum samples (collected at baseline and
      after dietary intervention) will be assessed. Participants will be randomised into two
      groups; the placebo group (consuming 6g of non-supplemented chocolate per day) and the
      supplemented group (consuming 6g of chocolate containing both soy and selenium per day). The
      intervention will last for the duration of one menstrual cycle.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2007</start_date>
  <completion_date type="Actual">August 2008</completion_date>
  <primary_completion_date type="Actual">May 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To determine the effect of supplementation with selenium and isoflavones on biomarkers of breast cancer risk.</measure>
    <time_frame>25-35 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Identify novel biomarkers of breast cancer risk through metabolomic analysis of samples collect.</measure>
    <time_frame>25-35 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">27</enrollment>
  <condition>Breast Cancer Risk</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>6g of chocolate (supplemented with selenium and isoflavones) per day for the duration of one menstrual cycle (25-35 days)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>6g of chocolate (control) per day for the duration of one menstrual cycle (25-35 days)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Soy and Selenium</intervention_name>
    <description>6g of chocolate per day Control group with no supplementation Active group 50mg of soy protein isolate + 200Âµg selenium in the form of MSC</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pre menopausal women (age 35-50)at moderate to high risk of breast cancer based on
             family history (NICE guidelines)

          -  Attending Breast Clinic at NNUH

          -  Willing to consume 6g of chocolate per day for 25-35 days

          -  Regular menstrual cycle of 25-35 days in length

        Exclusion Criteria:

          -  Current or previous diagnosis of breast cancer or cancer of any other site

          -  Diagnosis of hypertension (requiring active treatment)/diabetes/ coronary heart
             disease/ gastrointestinal disease/ any other systemic disease requiring treatment

          -  Regularly taking any prescribed medication within the last six months (including oral
             contraceptives)

          -  Fitted with a hormone releasing device

          -  Pregnant or lactating in the previous 12 months

          -  Using laxatives or antacids more than once a week

          -  Routinely taking soy or selenium supplements in the last twelve months

          -  Regularly taking any dietary or herbal supplements in the last six months

          -  Participation in any intervention study (soy or selenium) in the previous twelve
             months

          -  Parallel participation in another research study involving either dietary or medical
             intervention or sampling of biological fluids/materials

          -  Blood donation within sixteen weeks of study start/finish

          -  BMI &lt;18.5 or &gt;35

          -  Allergy to any chocolate/dairy/soy-based food products
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aedin Cassidy, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of East Anglia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institute of Food Research</name>
      <address>
        <city>Norwich</city>
        <state>Norfolk</state>
        <zip>NR4 7UA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Norfolk and Norwich University Hospital</name>
      <address>
        <city>Norwich</city>
        <state>Norfolk</state>
        <zip>NR4 7UY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of East Anglia</name>
      <address>
        <city>Norwich</city>
        <state>Norfolk</state>
        <zip>NR47TJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Akbaraly NT, Arnaud J, Hininger-Favier I, Gourlet V, Roussel AM, Berr C. Selenium and mortality in the elderly: results from the EVA study. Clin Chem. 2005 Nov;51(11):2117-23. Epub 2005 Aug 25.</citation>
    <PMID>16123147</PMID>
  </reference>
  <reference>
    <citation>Barnes S. Phytoestrogens and breast cancer. Baillieres Clin Endocrinol Metab. 1998 Dec;12(4):559-79. Review.</citation>
    <PMID>10384813</PMID>
  </reference>
  <reference>
    <citation>Bathen TF, Engan T, Krane J, Axelson D. Analysis and classification of proton NMR spectra of lipoprotein fractions from healthy volunteers and patients with cancer or CHD. Anticancer Res. 2000 Jul-Aug;20(4):2393-408.</citation>
    <PMID>10953302</PMID>
  </reference>
  <reference>
    <citation>Cassidy A, Bingham S, Setchell K. Biological effects of isoflavones in young women: importance of the chemical composition of soyabean products. Br J Nutr. 1995 Oct;74(4):587-601.</citation>
    <PMID>7577895</PMID>
  </reference>
  <reference>
    <citation>Cassidy A, Bingham S, Setchell KD. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr. 1994 Sep;60(3):333-40.</citation>
    <PMID>8074062</PMID>
  </reference>
  <reference>
    <citation>Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst. 1981 Jun;66(6):1191-308. Review.</citation>
    <PMID>7017215</PMID>
  </reference>
  <reference>
    <citation>Duncan AM, Merz BE, Xu X, Nagel TC, Phipps WR, Kurzer MS. Soy isoflavones exert modest hormonal effects in premenopausal women. J Clin Endocrinol Metab. 1999 Jan;84(1):192-7.</citation>
    <PMID>9920082</PMID>
  </reference>
  <reference>
    <citation>Duncan AM, Merz-Demlow BE, Xu X, Phipps WR, Kurzer MS. Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2000 Jun;9(6):581-6.</citation>
    <PMID>10868692</PMID>
  </reference>
  <reference>
    <citation>El-Bayoumy K, Sinha R. Mechanisms of mammary cancer chemoprevention by organoselenium compounds. Mutat Res. 2004 Jul 13;551(1-2):181-97. Review.</citation>
    <PMID>15225592</PMID>
  </reference>
  <reference>
    <citation>Fan S, Meng Q, Auborn K, Carter T, Rosen EM. BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells. Br J Cancer. 2006 Feb 13;94(3):407-26.</citation>
    <PMID>16434996</PMID>
  </reference>
  <reference>
    <citation>Grover PL, Martin FL. The initiation of breast and prostate cancer. Carcinogenesis. 2002 Jul;23(7):1095-102. Review.</citation>
    <PMID>12117765</PMID>
  </reference>
  <reference>
    <citation>Hu YJ, Diamond AM. Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res. 2003 Jun 15;63(12):3347-51.</citation>
    <PMID>12810669</PMID>
  </reference>
  <reference>
    <citation>Ip C. Lessons from basic research in selenium and cancer prevention. J Nutr. 1998 Nov;128(11):1845-54. Review.</citation>
    <PMID>9808633</PMID>
  </reference>
  <reference>
    <citation>Katdare M, Osborne M, Telang NT. Soy isoflavone genistein modulates cell cycle progression and induces apoptosis in HER-2/neu oncogene expressing human breast epithelial cells. Int J Oncol. 2002 Oct;21(4):809-15.</citation>
    <PMID>12239620</PMID>
  </reference>
  <reference>
    <citation>Lee SO, Nadiminty N, Wu XX, Lou W, Dong Y, Ip C, Onate SA, Gao AC. Selenium disrupts estrogen signaling by altering estrogen receptor expression and ligand binding in human breast cancer cells. Cancer Res. 2005 Apr 15;65(8):3487-92.</citation>
    <PMID>15833885</PMID>
  </reference>
  <reference>
    <citation>Li J, Orlandi R, White CN, Rosenzweig J, Zhao J, Seregni E, Morelli D, Yu Y, Meng XY, Zhang Z, Davidson NE, Fung ET, Chan DW. Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry. Clin Chem. 2005 Dec;51(12):2229-35. Epub 2005 Oct 13.</citation>
    <PMID>16223889</PMID>
  </reference>
  <reference>
    <citation>LÃ¼ J, Jiang C. Selenium and cancer chemoprevention: hypotheses integrating the actions of selenoproteins and selenium metabolites in epithelial and non-epithelial target cells. Antioxid Redox Signal. 2005 Nov-Dec;7(11-12):1715-27. Review.</citation>
    <PMID>16356132</PMID>
  </reference>
  <reference>
    <citation>Messina MJ, Loprinzi CL. Soy for breast cancer survivors: a critical review of the literature. J Nutr. 2001 Nov;131(11 Suppl):3095S-108S. doi: 10.1093/jn/131.11.3095S. Review.</citation>
    <PMID>11694655</PMID>
  </reference>
  <reference>
    <citation>Odunsi K, Wollman RM, Ambrosone CB, Hutson A, McCann SE, Tammela J, Geisler JP, Miller G, Sellers T, Cliby W, Qian F, Keitz B, Intengan M, Lele S, Alderfer JL. Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics. Int J Cancer. 2005 Feb 20;113(5):782-8.</citation>
    <PMID>15499633</PMID>
  </reference>
  <reference>
    <citation>Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967 Jul;70(1):158-69.</citation>
    <PMID>6066618</PMID>
  </reference>
  <reference>
    <citation>Shah YM, Al-Dhaheri M, Dong Y, Ip C, Jones FE, Rowan BG. Selenium disrupts estrogen receptor (alpha) signaling and potentiates tamoxifen antagonism in endometrial cancer cells and tamoxifen-resistant breast cancer cells. Mol Cancer Ther. 2005 Aug;4(8):1239-49.</citation>
    <PMID>16093440</PMID>
  </reference>
  <reference>
    <citation>Rinaldi S, Peeters PH, Berrino F, Dossus L, Biessy C, Olsen A, Tjonneland A, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, TÃ©hard B, Nagel G, Linseisen J, Boeing H, Lahmann PH, Trichopoulou A, Trichopoulos D, Koliva M, Palli D, Panico S, Tumino R, Sacerdote C, van Gils CH, van Noord P, Grobbee DE, Bueno-de-Mesquita HB, Gonzalez CA, Agudo A, Chirlaque MD, Barricarte A, LarraÃ±aga N, Quiros JR, Bingham S, Khaw KT, Key T, Allen NE, Lukanova A, Slimani N, Saracci R, Riboli E, Kaaks R. IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer. 2006 Jun;13(2):593-605.</citation>
    <PMID>16728585</PMID>
  </reference>
  <reference>
    <citation>Solanky KS, Bailey NJ, Beckwith-Hall BM, Davis A, Bingham S, Holmes E, Nicholson JK, Cassidy A. Application of biofluid 1H nuclear magnetic resonance-based metabonomic techniques for the analysis of the biochemical effects of dietary isoflavones on human plasma profile. Anal Biochem. 2003 Dec 15;323(2):197-204.</citation>
    <PMID>14656525</PMID>
  </reference>
  <reference>
    <citation>Solanky KS, Bailey NJ, Beckwith-Hall BM, Bingham S, Davis A, Holmes E, Nicholson JK, Cassidy A. Biofluid 1H NMR-based metabonomic techniques in nutrition research - metabolic effects of dietary isoflavones in humans. J Nutr Biochem. 2005 Apr;16(4):236-44.</citation>
    <PMID>15808328</PMID>
  </reference>
  <reference>
    <citation>Trock BJ, Hilakivi-Clarke L, Clarke R. Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst. 2006 Apr 5;98(7):459-71.</citation>
    <PMID>16595782</PMID>
  </reference>
  <reference>
    <citation>Tsubura A, Uehara N, Kiyozuka Y, Shikata N. Dietary factors modifying breast cancer risk and relation to time of intake. J Mammary Gland Biol Neoplasia. 2005 Jan;10(1):87-100. Review.</citation>
    <PMID>15886889</PMID>
  </reference>
  <reference>
    <citation>Whanger PD. Selenium and its relationship to cancer: an update. Br J Nutr. 2004 Jan;91(1):11-28. Review.</citation>
    <PMID>14748935</PMID>
  </reference>
  <reference>
    <citation>Xiang H, Schevzov G, Gunning P, Williams HM, Silink M. A comparative study of growth-inhibitory effects of isoflavones and their metabolites on human breast and prostate cancer cell lines. Nutr Cancer. 2002;42(2):224-32.</citation>
    <PMID>12416264</PMID>
  </reference>
  <reference>
    <citation>Xu X, Duncan AM, Merz BE, Kurzer MS. Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women. Cancer Epidemiol Biomarkers Prev. 1998 Dec;7(12):1101-8.</citation>
    <PMID>9865428</PMID>
  </reference>
  <reference>
    <citation>Yang J, Xu G, Zheng Y, Kong H, Pang T, Lv S, Yang Q. Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases. J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Dec 25;813(1-2):59-65.</citation>
    <PMID>15556516</PMID>
  </reference>
  <reference>
    <citation>Zhang J, SvehlÃ­kovÃ¡ V, Bao Y, Howie AF, Beckett GJ, Williamson G. Synergy between sulforaphane and selenium in the induction of thioredoxin reductase 1 requires both transcriptional and translational modulation. Carcinogenesis. 2003 Mar;24(3):497-503.</citation>
    <PMID>12663510</PMID>
  </reference>
  <reference>
    <citation>Nutritional aspects of the development of cancer. Report of the Working Group on Diet and Cancer of the Committee on Medical Aspects of Food and Nutrition Policy. Rep Health Soc Subj (Lond). 1998;48:i-xiv, 1-274. Review.</citation>
    <PMID>9599404</PMID>
  </reference>
  <reference>
    <citation>Clemons M, Goss P. Estrogen and the risk of breast cancer. N Engl J Med. 2001 Jan 25;344(4):276-85. Review. Erratum in: N Engl J Med 2001 Jun 7;344(23):1804.</citation>
    <PMID>11172156</PMID>
  </reference>
  <verification_date>September 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 7, 2007</study_first_submitted>
  <study_first_submitted_qc>November 7, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 8, 2007</study_first_posted>
  <last_update_submitted>September 24, 2008</last_update_submitted>
  <last_update_submitted_qc>September 24, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 25, 2008</last_update_posted>
  <responsible_party>
    <name_title>Professor Aedin Cassidy</name_title>
    <organization>University of East Anglia</organization>
  </responsible_party>
  <keyword>Selenium</keyword>
  <keyword>Soy</keyword>
  <keyword>Breast Cancer Risk</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Selenium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

